Recent studies suggest that nicotinamide phosphor-ribosyl-transferase (NAMPT)—a major rate-limiting enzyme and mandatory metabolic cofactor—is required for relapse of AML stem cells. This evidence concerns the gene NAMPT and acute myeloid leukemia.